#	Pagina
attuale pagina	/open-h2020/projects/211378/index.html

Opendata, web and dolomites

XANA SIGNED

Innovative Wearable and Open Platform for a Personalized Treatment of Stress

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

XANA project word cloud

Explore the words cloud of the XANA project. It provides you a very rough idea of what is the project "XANA" about.

limited 12 secondary solution billion hire 1 15 start efficacy benchmark clear employees treatment fast public ultimately xana stress investment invasive 26 mostly productivity avoidance remote expensive pharmacological friendliness led mobile techniques mental actual 2002 benefits suffered generate world healthcare nerve physiological prevalence ict ease counselling indirect optimisation sales paid medical health device stimulation customized anxiety profit walden technologies consuming alternatives wearable professional earn economies monitoring national 28m 700 69 10m direct possibly impacting commercialization burden innovative population international time electrical services vagus performance spanish launch feedback reg market psychological migraine

Project "XANA" data sheet

The following table provides information about the project.

Coordinator	WALDEN MEDICAL NEURO DIGITAL THERAPIES, S.L. Organization address address: C/ LOS PRADOS 166 city: GIJON postcode: 33203 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Project website	https://www.waldenmedical.com/
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
Code Call	H2020-SMEINST-1-2016-2017
Funding Scheme	SME-1
Starting year	2017
Duration (year-month-day)	from 2017-08-01 to 2017-11-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	WALDEN MEDICAL NEURO DIGITAL THERAPIES, S.L. WALDEN MEDICAL NEURO DIGITAL THERAPIES, S.L. Organization address address: C/ LOS PRADOS 166 city: GIJON postcode: 33203 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (GIJON)	coordinator	50˙000.00

Map

Project objective

The XANA project aims at developing a user-friendly wearable device and ICT solution for the customized treatment of stress. We will provide an innovative and non-invasive technology of stimulation of the vagus nerve and a range of integrated services such as feedback on performance, monitoring and access to professional counselling when needed.

Stress is suffered by over 26% of working population. The European Commission estimated in 2002 the cost of work-related stress at €20 billion a year just in the EU-15. Of this, direct costs are mostly paid by the public healthcare systems, and indirect costs are related to productivity loss, ultimately impacting national economies.

Current alternatives do not fully solve the challenge of stress treatment, because of their limited efficacy and presence of secondary effects (invasive electrical stimulation or pharmacological treatment). Moreover, the treatment results are very variable, time consuming (psychological techniques) and expensive. XANA main benefits are: avoidance of secondary effects, high efficacy, user-friendliness, fast and customized treatment providing actual physiological activity. XANA will contribute to the development of mobile Health in Europe. In this, the ICT characteristics of the product are key to possibly enabling burden-reduction in healthcare systems through real-time treatment optimisation and remote medical monitoring/counselling.

XANA project is led by the Spanish start-up Walden Medical®. XANA has a clear potential for becoming an international benchmark in the field of mental health. We have estimated that after 5 years from launch, we will build around 69.700 devices (sales €28M), hire 12 technical employees and manage 0.1% of the world market. We will earn around €10M profit and generate a R.O.I of 6.90. Investment in the XANA product will furthermore ease commercialization of Walden Medical® technologies for other high prevalence conditions: anxiety and migraine.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "XANA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "XANA" are provided by the European Opendata Portal: CORDIS opendata.